Shots: The US FDA has issued EUA for Abbott’s molecular test for COVID-19 and will be used on the m2000 RealTime system which is currently available in hospitals and molecular […]readmore
Shots: CEPI reports its seventh COVID-19 vaccine project and will invest $620,000 to HKU for the development of vaccine candidate against COVID-19, making the total investment of CEPI’s in COVID-19 […]readmore
Shots: The US FDA has issued guidance to aid sponsors & IRBs for assuring the safety of participants in clinical studies, maintaining compliance with GCP and to reduce the risk […]readmore
Shots: Eli Lilly partnered with the Indiana State Department of Health, in support from FDA to hasten testing for SARS-CoV-2 in Indiana Eli Lilly will utilize its research laboratories for […]readmore
Shots: The P-III COVACTA study will evaluate the safety and efficacy of Actemra/RoActemra (tocilizumab) + SOC vs PBO + SOC in adult hospitalized patients with severe COVID-19 pneumonia The study […]readmore
Shots: Regeneron advances its program to discover and develop a novel multi-Ab cocktail, administered as prophylaxis before exposure to the SARS-CoV-2 virus or as a treatment for already infected patients […]readmore
Shots: Moleculin will provide its lead candidate, WP1122, and related inhibitors along with technical support while UTMB will investigate candidates against multiple viruses including COVID-19, in connection with UTMB’s CBEID […]readmore
Shots: The study involves assessing of investigational vaccine mRNA-1273 against COVID-19 enrolling 45 patients with age of 18 to 55 years ~6wks. and the first patient has been dosed. Additionally, […]readmore
Shots: From Mar 16, 2020, the Californians availed an online COVID-19 screener survey and till date, the site has run out of appointments. The people who met the eligibility criteria […]readmore
Shots: The companies collaborate to accelerate the development of BioNTech’s BNT162, which is anticipated to enter clinical studies by the end of Apr’2020. The alliance will leverage the expertise and […]readmore